GPT HEALTHCARE LIMITED
₹ 177 - ₹ 186
22-Feb-2024 - 26-Feb-2024
₹ 14880.00

/ 80 Shares

GPT HEALTHCARE LIMITED

22-Feb-2024 - 26-Feb-2024

₹ 177 - ₹ 186

Price Band

₹ 14880.00

Minimum Investment

80

Bid Lot

28,233,323

Shares
  • Face Value - ₹ 10/- Per Share

  • Listing at NSE BSE

  • 123,520 Application Required in Retail for 1 Time.

  • Registrar : Link Intime India Private Ltd

IPO Details

Fresh Issue of Equity shares aggregating upto Rs. 40 Cr and offer for sale of 26,082,786 Equity Shares.

Category % Shares/Amount
QIB 50% 14,116,660 Shares Rs.262.57 Cr
HNI 1 5% 1,411,667 Shares Rs.26.26 Cr @ 1260 Form 1X
HNI 2 10% 2,823,332 Shares Rs.52.51 Cr @ 2521 Form 1X
Retail 35% 9,881,664 Shares Rs.183.80 Cr @ 123521 Form 1X

JM Financial Services Ltd


Application Require for 1 Time

Retail (Upto 2 Lakh) HNI (2 Lakh to 10 Lakh) HNI (Above 10 Lakh)
123521 Form 1X 1260 Form 1X 2521 Form 1X

IPO Lot Size

Category Lots Shares Amount
Retail (Upto 2 Lakh) 1 80 ₹ 14,880
Retail (Upto 2 Lakh) 13 1040 ₹ 193,440
S-HNI (2 Lakh to 10 Lakh) 14 1120 ₹ 208,320
S-HNI (2 Lakh to 10 Lakh) 67 5360 ₹ 996,960
B-HNI (Above 10 Lakh) 68 5440 ₹ 1,011,840

IPO Timeline

  • Open Date

    22-Feb-2024
  • Close Date

    26-Feb-2024
  • Basis of Allotment Date

    27-Feb-2024
  • Initiation of Refunds

    28-Feb-2024
  • Credit Shares to Demat A/c

    28-Feb-2024
  • IPO Listing Date

    29-Feb-2024

Subscription as on
26-Feb-2024 16:06

Category Book Size Subscription No. of Times
QIB 5,646,664 ₹ 105.03 Cr. 97,684,000 ₹ 1816.92 Cr. 17.30x
HNI (<10 LAKH) 1,411,667 ₹ 26.26 Cr. 11,436,560 ₹ 212.72 Cr. 8.10x
HNI2 (>10 LAKH) 2,823,332 ₹ 52.51 Cr. 33,818,720 ₹ 629.03 Cr. 11.98x
RETAIL 9,881,664 ₹ 183.80 Cr. 22,550,080 ₹ 419.43 Cr. 2.28x
Total 19,763,327 165,489,360 8.37x
Category Book Size Subscription No. of Times
QIB 5,646,664 ₹ 105.03 Cr. 97,684,000 ₹ 1816.92 Cr. 17.30x
HNI (<10 LAKH) 1,411,667 ₹ 26.26 Cr. 11,436,560 ₹ 212.72 Cr. 8.10x
HNI2 (>10 LAKH) 2,823,332 ₹ 52.51 Cr. 33,818,720 ₹ 629.03 Cr. 11.98x
RETAIL 9,881,664 ₹ 183.80 Cr. 22,550,080 ₹ 419.43 Cr. 2.28x
Total 19,763,327 165,489,360 8.37x

*Excluding Anchor

Total No. of Application Approx : ~224967 (1.82 Appwise)

Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.

About Company

  • Founded by Dr. Om Tantia, GPT Healthcare Ltd (“ILS Hospitals”) was incorporated on August 13, 2004.  ILS Hospitals is one of the key regional corporate healthcare companies in Eastern India in terms of number of beds and hospitals as of Fiscal Year 2023. The company operates a chain of mid-sized full-service hospitals under the         brand and provides integrated healthcare services, with a focus on secondary and tertiary care. As of September 30, 2023, they operate 4 multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds.

  • The company offers a comprehensive range of healthcare services across over 35 specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.

  • The company’s 1st hospital in their network was established in Salt Lake, Kolkata (West Bengal) in the year 2000 with a capacity of 8 beds, which has grown to 85 beds, including 17 beds across various ICUs and HDUs as of September 30, 2023.

  • The 2nd hospital was set up in Agartala (Tripura) in the year 2011 and has a capacity of 205 beds as of September 30, 2023, including 66 beds across various ICUs and HDUs.

  • Their 3rd hospital in Dum Dum, Kolkata (West Bengal), established in the year 2013, has 155 beds, including 53 beds across various ICUs and HDUs as of September 30, 2023. It is authorized to perform renal transplants.

  • The 4th hospital in Howrah (West Bengal) was commissioned in the year 2019, with 116 beds including 43 beds across ICUs and HDUs as of September 30, 2023.

  • The company has 1,902 employees, 91 full-time consultants, and 481 visiting consultants as of September 30, 2023. Each of their hospitals is managed by a Chief Operating Officer, who is responsible for supervising day-to-day functioning.

  • Company’s revenue from operations (ex-COVID) grown at a CAGR of 53.87% over FY2021 to FY2023 and ROCE being 26.09% for FY2023.

Read More

Strengths

Competitive Strength 

  • Key regional corporate healthcare company with a strong foothold in under-penetrated and densely populated healthcare delivery markets;
  • ‘Right-sized’, full service and strategically located hospitals leading to high return on capital;
  • Well diversified specialty mix and location mix;
  • Ability to attract, train and retain quality medical professionals;
  • Track record of operating and financial performance and growth;
  • Professional management and experienced leadership;
  • Investment in infrastructure, processes and clinical excellence driving affordability, and a strong value proposition for stakeholders.

Business Strategies 

  • Strengthen the existing hospitals and offerings and add new capabilities and specialties;
  • Strategically grow the presence in adjacent markets;
  • Focus on flexible and asset-light expansion for quick break-even;
  • Implementation of initiatives to improve existing operational efficiencies.

Company Promoters

Dwarika Prasad Tantia is the Executive Chairman of the company. Dr. Om Tantia is the Managing Director of the company. Anurag Tantia is the Whole time Director of the company. Dr Aruna Tantia is the non-executive director of the company. Dr Ghanshyam Goyal is the non-executive director of the company. Kashi Prasad Khandelwal is an independent director of the company. Tapti Sen is an independent director of the company. Hari Modi is an independent director of the company. Deepak Pramanik

Company Financials

GPT Healthcare Limited's revenue increased by 7.11% and profit after tax (PAT) dropped by -6.37% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended 30 Sep 2023 31 Mar 2023 31 Mar 2022 31 Mar 2021
Assets 332.09 326.76 323.22 317.21
Revenue 206.70 366.73 342.40 248.86
Profit After Tax 23.49 39.01 41.66 21.09
Net Worth 171.43 164.14 156.96 132.68
Reserves and Surplus 92.75 85.46 78.28 75.96
Total Borrowing 55.57 64.67 95.52 122.93
Amount in ? Crore

Objects of the Issue

  1. Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the company from banks and financial institutions; and
  2. General corporate purposes.

How to Apply

Apply for IPO in few simple steps.

  • Step 01 :

    Once you create your account, Login to InvestoYard.

  • Step 02 :

    Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.

  • Step 03 :

    Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).

  • Step 04 :

    Enter your UPI ID and you will receive mandate on your UPI App.

  • Step 05 :

    Once you accept the mandate, Application is submitted successful.

  • Applying for an IPO is easier than ever with InvestoYard, in just a few clicks your application is processed. You can bid for any IPO through InvestoYard, the bidding process is simple and hassle free. Every company has a lot size decided & you can buy in multiples of the decided lot.
  • If lot size is 15, then you have to bid for multiples of 15 share like 30,45,60 and so on.
  • The maximum subscription amount for retail investors is 2 lakh.
  • Any bid can be at a desired price or cut off price given by the company.

  • Enter the number of shares you wish to buy, as per the lot size.
  • You can apply at the cut off price set by the company or bid for a desired amount within the price band.
  • Maximum three bids will be accepted.
  • You then need to enter the UPI ID on InvestoYard’s IPO application form.

  • You will immediately get a fund blocked request on your UPI for the submitted IPO application.
  • The funds will be blocked in your bank account until allotment when it is debited.
  • The limit for IPO application is Rs 2 lakh per transaction on UPI.
  • On allotment of the shares, the money will be automatically debited.
  • If the share aren’t allotted the blocked funds will reflect back into your account.

Frequently Asked Questions

Check Allotment